Lenacapavir is a multistage, selective inhibitor of HIV-1 capsid function that directly binds to the interface between capsid protein (p24) subunits in hexamers. Surface plasmon resonance sensorgrams ...
Pharmaceutical Technology on MSN
JPM26: Solid Biosciences banks on its AAV capsid to catalyse gene therapy success
The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback